MicroTech Medical Hong Kong IPO Greeted with Yawns
Diabetes device maker’s shares go largely unchanged in first four trading days despite attracting Invesco and two other mid-sized U.S. fund managers Key Takeaways: Diabetes device maker MicroTech Medical’s shares…
Recent Articles
RELATED ARTICLES
- Innogen Pharma jostles for a slice of the weight-loss market
-
Airdoc Tech enjoys healing properties of medical AI rally
2251.HK
- PegBio aims to bulk up its finances to deliver weight-loss drugs
- Breton eyes big haul from investors with Hong Kong IPO plan
-
Xuanzhu Biopharm set for spin-off in Hong Kong IPO
0460.HK
- Eternal Beauty struts its stuff as Hong Kong’s newest IPO contestant
Discover hidden China stock gems in our weekly newsletter